Tech Company Inital Public Offerings
Landos Biopharma IPO
Based in Blacksburg, Landos Biopharma is now a public company.
Transaction Overview
Company Name
Announced On
2/4/2021
Transaction Type
IPO
Amount
$100,000,000
Proceeds Purpose
Use of proceeds for the Landos Biopharma IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1800 Kraft Dr. 216
Blacksburg, VA 24060
USA
Blacksburg, VA 24060
USA
Phone
Undisclosed
Website
Email Address
Overview
Landos' unique core platform technology enables accelerated development of safer, more effective oral, first-in-class therapeutics for autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Josep Bassaganya-Riera
Chief Medical Officer
Simon Lichtiger
Chief Scientific Officer
Raquel Hontecillas
Chief Scientific Officer
Andrew Leber
VP - Finance
Jennifer Collette
VP - Regulatory Affairs
Jyoti Chauhan
Browse more venture capital transactions:
Prev: 2/4/2021: SpectraWAVE venture capital transaction
Next: 2/4/2021: Leadspace venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs